Tyrosols and derivatives
Apexbio Technology LLC VX-702 479543-46-9; 745833-23-2 50mg
VX-702 is a small-molecule inhibitor targeting p38 mitogen-activated protein kinase (MAPK) also known as MAPK14 It is designed to inhibit p38 MAPK thereby regulating cellular responses to cytokine signaling and various stressors VX-702 exerts its biological activity primarily through ATP-competitive inhibition In experimental models VX-702 demonstrates potent inhibition with reported IC50 values ranging from 4 to 20 nM Based on these pharmacological properties VX-702 holds research potential in the study of p38 MAPK-dependent pathways platelet storage lesions and renal excretion mechanisms
Medchemexpress LLC Abt-702 dihydrochloride | 1188890-28-9 | 99.8% | 536.25 g/mol | C22H21BrCl2N6O | 100 MG
ABT-702 dihydrochloride is a potent, non-nucleoside adenosine kinase (AK) inhibitor (IC50 = 1.7 nM), supplied as the dihydrochloride salt for research use. It is used in biochemical and cellular studies to modulate adenosine kinase activity.
- Potent adenosine kinase inhibitor with IC50 = 1.7 nM.
- Dihydrochloride salt form for improved stability and solubility.
- Molecular formula C22H21BrCl2N6O; molecular weight 536.25 g/mol.
- Intended for research use in biochemical and cellular assays.
- Store sealed away from moisture; in solvent, -80°C (up to 6 months) or -20°C (up to 1 month).
eMolecules ChemScene / 246-Tribromophenyl methacrylate / 1g / 625603901 / CS-0179372 / 0.000 / 37721-71-4 / MFCD00078329 / 398.876 / C10H7Br3O2
ChemScene / 246-Tribromophenyl methacrylate / 1g / 625603901 / CS-0179372 / 0.000 / 37721-71-4 / MFCD00078329 / 398.876 / C10H7Br3O2
Apexbio Technology LLC Verbascoside 61276-17-3 100mg
Verbascoside (CAS 61276-17-3) is a small-molecule inhibitor targeting protein kinase C (PKC) and the NF- B signaling pathway It is designed to modulate these pathways thereby regulating signal transduction and transcriptional activity in cellular responses Verbascoside exerts its biological activity primarily through the inhibition of PKC and suppression of NF- B DNA-binding activation In cell-based studies Verbascoside demonstrates inhibitory activity with an IC50 value of approximately 4 8 M in RANKL-treated RAW264 7 cells and bone marrow macrophages (BMMs) Based on these pharmacological properties Verbascoside holds research potential in the investigation of PKC/NF- B-mediated signaling osteoclastogenesis and related cell signaling mechanisms
Selleck Chemical LLC ABT 702 dihydrochloride
ABT-702 is a novel potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1 7 nM It has oral activity in animal models of pain and inflammation
Apexbio Technology LLC VX-702 479543-46-9; 745833-23-2 10mM (in 1mL DMSO)
VX-702 is a small-molecule inhibitor targeting p38 mitogen-activated protein kinase (MAPK) also known as MAPK14 It is designed to inhibit p38 MAPK thereby regulating cellular responses to cytokine signaling and various stressors VX-702 exerts its biological activity primarily through ATP-competitive inhibition In experimental models VX-702 demonstrates potent inhibition with reported IC50 values ranging from 4 to 20 nM Based on these pharmacological properties VX-702 holds research potential in the study of p38 MAPK-dependent pathways platelet storage lesions and renal excretion mechanisms
Sigma Aldrich Fine Chemicals Biosciences Metoprolol tartrate United States Pharmacopeia (USP) Reference Standard | 56392-17-7 | MFCD00056257 | 200MG
Metoprolol tartrate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 684.81 | 56392-17-7 | MFCD00056257 | 200MG
